{"cluster": 57, "subcluster": 3, "abstract_summ": "Background In hospitalized patients with COVID-19 pneumonia, progression to acute respiratory failure requiring invasive mechanical ventilation (MV) is associated with significant morbidity and mortality.Methods We conducted a multicenter, observational study to explore the association between exposure to prolonged, low-dose, MP treatment and need for ICU referral, intubation or death within 28 days (composite primary endpoint) in patients with severe COVID-19 pneumonia admitted to Italian respiratory high-dependency units.Conclusion In patients with severe COVID-19 pneumonia, early administration of prolonged MP treatment was associated with a significantly lower hazard of death (71%) and decreased ventilator dependence.Background: Severe patients with 2019 novel coronavirus (2019-nCoV) pneumonia progressed rapidly to acute respiratory failure.OBJECTIVE To observe the clinical effect of plasma exchange and tocilizumab in treatment of patients with severe coronavirus disease 2019 (COVID-19).", "title_summ": "Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical CasesEarly Short Course Corticosteroids in Hospitalized Patients with COVID-19Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary ReportGLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumoniaOzone therapy for patients with SARS-COV-2 pneumonia: a single-center prospective cohort studyProlonged low-dose methylprednisolone in patients with severe COVID-19 pneumoniaEarly, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China[Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab].Early Short Course Corticosteroids in Hospitalized Patients with COVID-19", "title_abstract_phrases": "Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, ChinaBackground: Severe patients with 2019 novel coronavirus (2019-nCoV) pneumonia progressed rapidly to acute respiratory failure.Conclusion: Our data indicate that in patients with severe COVID-19 pneumonia, early, low-dose and short-term application of corticosteroid was associated with a faster improvement of clinical symptoms and absorption of lung focus.[Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab].OBJECTIVE To observe the clinical effect of plasma exchange and tocilizumab in treatment of patients with severe coronavirus disease 2019 (COVID-19).Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumoniaBackground In hospitalized patients with COVID-19 pneumonia, progression to acute respiratory failure requiring invasive mechanical ventilation (MV) is associated with significant morbidity and mortality.Participants: Eighteen consecutive patients with laboratory confirmed COVID-19 infection and severe pneumonia who were admitted to hospital between 20th March and 19th April 2020.Methods We conducted a multicenter, observational study to explore the association between exposure to prolonged, low-dose, MP treatment and need for ICU referral, intubation or death within 28 days (composite primary endpoint) in patients with severe COVID-19 pneumonia admitted to Italian respiratory high-dependency units."}